CN Patent

CN116283928A — 一种哒嗪类化合物、其制备方法和应用

Assigned to Ailikang Pharmaceutical Co ltd · Expires 2023-06-23 · 3y expired

What this patent protects

本发明涉及一种如式I所示的一种哒嗪类化合物及其立体异构体、或其药学上可接受的盐、其制备方法、组合物和应用。本发明的Tyk2抑制剂化合物及其异构体、或其药学可接受的盐能够降低Tyk2的酶活性，预防和/或治疗与Tyk2抑制有关的适应症，比如多发性硬化症、类风湿性关节炎、强直性脊柱炎、炎性肠病、系统性红斑狼疮、银屑病、银屑病性关节炎、克罗恩病、舍格伦综合征或硬皮病。

USPTO Abstract

本发明涉及一种如式I所示的一种哒嗪类化合物及其立体异构体、或其药学上可接受的盐、其制备方法、组合物和应用。本发明的Tyk2抑制剂化合物及其异构体、或其药学可接受的盐能够降低Tyk2的酶活性，预防和/或治疗与Tyk2抑制有关的适应症，比如多发性硬化症、类风湿性关节炎、强直性脊柱炎、炎性肠病、系统性红斑狼疮、银屑病、银屑病性关节炎、克罗恩病、舍格伦综合征或硬皮病。

Drugs covered by this patent

Patent Metadata

Patent number
CN116283928A
Jurisdiction
CN
Classification
—
Expires
2023-06-23
Drug substance claim
No
Drug product claim
No
Assignee
Ailikang Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.